GOLDMAN SACHS GROUP INC - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 85 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q3 2022$15
-37.5%
88,583
-7.5%
0.00%
Q2 2022$24
-100.0%
95,738
+12.0%
0.00%
Q4 2021$53,000
-66.9%
85,491
-45.4%
0.00%
Q3 2021$160,000
+41.6%
156,720
+154.8%
0.00%
Q2 2021$113,000
-73.3%
61,514
-71.4%
0.00%
Q1 2021$423,000
+456.6%
214,971
+253.5%
0.00%
Q4 2020$76,000
-77.8%
60,816
-68.1%
0.00%
Q3 2020$343,000
-40.8%
190,753
+176.4%
0.00%
Q2 2020$579,000
+53.2%
69,014
-4.4%
0.00%
Q1 2020$378,000
+17.4%
72,172
+22.3%
0.00%
Q4 2019$322,000
-24.2%
58,989
-32.5%
0.00%
Q3 2019$425,000
-46.7%
87,346
-24.0%
0.00%
Q2 2019$797,000
-36.9%
114,975
-36.8%
0.00%
Q1 2019$1,263,000
-15.2%
181,797
-28.7%
0.00%
Q4 2018$1,490,000
+84.2%
255,010
+138.0%
0.00%
Q3 2018$809,000
+179.0%
107,128
+86.4%
0.00%
Q2 2018$290,000
-10.8%
57,466
+7.7%
0.00%
Q1 2018$325,000
+48.4%
53,333
+72.7%
0.00%
Q4 2017$219,00030,8850.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q4 2021
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$42,335,00024.44%
MANGROVE PARTNERS IM, LLC 552,200$4,633,0001.13%
ETF MANAGERS GROUP, LLC 3,707,912$31,109,0001.10%
Ikarian Capital, LLC 1,350,000$11,327,0000.90%
GENERAL AMERICAN INVESTORS CO INC 712,400$5,977,0000.76%
AdvisorShares Investments LLC 189,814$1,593,0000.68%
Ikarian Capital, LLC 1,000,000$8,390,0000.67%
Granite Point Capital Management, L.P. 1,123,600$9,427,0000.48%
Carmignac Gestion 3,773,440$31,659,0000.44%
Omnia Family Wealth, LLC 32,356$271,467,0000.27%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders